7-FLUORO-2,3,11,11A-TETRAHYDRO-8-METHYL-6-(1-METHYLETHOXY)-2-((1,2,3,4-TETRAHYDRO-2-OXO-1,6-NAPHTHYRIDIN-7-YL)OXY)-1H,5H-PYRROLO(2,1-C)(1,4)BENZOXAZEPIN-5-ONE, (2S,11AR)-
UNII 47KBG9YG3C
Substance Identification & Data
This profile provides standardized clinical and technical data for 7-fluoro-2,3,11,11a-tetrahydro-8-methyl-6-(1-methylethoxy)-2-((1,2,3,4-tetrahydro-2-oxo-1,6-naphthyridin-7-yl)oxy)-1h,5h-pyrrolo(2,1-c)(1,4)benzoxazepin-5-one, (2s,11ar)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 47KBG9YG3C.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3002047-97-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C24H26FN3O5 XRTCPNNIIMSSJK-CVEARBPZSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 7-fluoro-2,3,11,11a-tetrahydro-8-methyl-6-(1-methylethoxy)-2-((1,2,3,4-tetrahydro-2-oxo-1,6-naphthyridin-7-yl)oxy)-1h,5h-pyrrolo(2,1-c)(1,4)benzoxazepin-5-one, (2s,11ar)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.